Section 1: Legislation - Medsafe
Section 1: Legislation . Section summary This section identifies the legislation and guidelines to be read in conjunction with this part of the regulatory guidelines.
Download Section 1: Legislation - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzTreatment of recurrent, platinum-resistant disease: 10 mg/kg body weight given once every 2 weeks when administered in combination with one of …
Madopar (levodopa) Data Sheet (DS) - Medsafe
medsafe.govt.nzMADOPAR 160202 1 Data Sheet MADOPAR® Levodopa + benserazide Capsules 62.5, 125 and 250; dispersible tablet 62.5; HBS modified-release capsule 125
Section 1: Legislation relating to the labelling - …
medsafe.govt.nzPart 5, Ed 1.6 Page 2 of 18 . Section 1: Legislation relating to the labelling of medicines and related products Section summary This section lists the legislation regulating the labelling of medicines and related products.
NEW ZEALAND DATA SHEET VERMOX® - …
medsafe.govt.nzNEW ZEALAND DATA SHEET VERMOX® Vermox® Page 2 of 7 For control of enterobiasis Adults and children 2-12 years: 1 Vermox tablet (100 mg) or 5 mL of suspension (100 mg) is given.
Guideline on the Regulation of Therapeutic …
medsafe.govt.nzGuideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0
Clonazepam: oral drops (2.5 mg/ml); injection (1 mg).
medsafe.govt.nz2. you have severe and chronic lung disease 3. you have severe liver disease 4. you have an addiction to drugs or alcohol 5. the package is torn or shows signs of tampering
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzNEW ZEALAND DATA SHEET 5 Hypnovel 170717 Medical history of alcohol or drug abuse Hypnovel should be avoided in patients with a medical history of alcohol or drug abuse.
SCHEDULE OF FEES (effective from 1 July 2018)
medsafe.govt.nzPage 1 of 10. SCHEDULE OF FEES (effective from 1 July 2018) • All fees listed are GST inclusive. • More detailed descriptions of the type of application or change to which a fee applies can be
Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets
medsafe.govt.nz1 Nortriptyline NRIM 09052013 NEW ZEALAND DATA SHEET Nortriptyline NRIM . Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets . This product may not be interchangeable with similar products on the New Zealand market
2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3 ...
medsafe.govt.nz1. PRODUCT NAME LOSARTAN ACTAVIS (Losartan Potassium 12.5mg, 25mg, 50mg and 100mg Tablets) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains: 12.5 mg losartan potassium 25 mg losartan potassium 50 mg losartan potassium 100mg losartan potassium . For the full list of excipients, see section 6.1. 3. …
Related documents
Medicines New Zealand Incorporated Code of …
www.medicinesnz.co.nzPage | 1 Medicines New Zealand Code of Practice Edition 16. Effective from 5 August 2014 Medicines New Zealand Incorporated Code of Practice
Section 1: Legislation relating to the labelling - …
medsafe.govt.nzPart 5, Ed 1.6 Page 2 of 18 . Section 1: Legislation relating to the labelling of medicines and related products Section summary This section lists the legislation regulating the labelling of medicines and related products.